Normethermic Intraperitoneal Chemotherapy - a Novel Concept for Local Treatment of the Elderly and Fragile Women With Advanced Ovarian Cancer?

The purpose of this feasibility study is to investigate whether NIPEC with carboplatin after surgery is safe for the elderly and frail women with advanced ovarian cancer. To achieve this, women with advanced ovarian cancer who receive surgery followed by NIPEC will be closely monitored in the period after treatment. We will assess complications, side effects, recovery after surgery and NIPEC, and whether standard chemotherapy can be started on time and completed as planned. In addition, participants will be followed for six months using questionnaires and interviews to evaluate patient-repor

Trial Details

NCT ID
NCT07733505
Phase
PHASE1
Sponsor
Odense University Hospital
Status
RECRUITING
Cancer Type
Ovarian Cancer
Interventions
  • Normethermic Intraperitoneal Chemotherapy with carboplatin
Locations (sample)
  • Odense, Denmark|55.39594,10.38831

Key Eligibility Criteria

  • Signed informed consent.
  • Patient capability of giving informed consent.
  • Age ≥ 70 years.
  • Women diagnosed with epithelial ovarian cancer, fallopian tube cancer, peritoneal cancer FIGO stage III-IV with planned interval cytoreductive surg…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Ovarian Cancer Trials on Trialify →